Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
Market Analysis and Insights: Global Gene-based Advanced Therapy Medicinal Market
The global Gene-based Advanced Therapy Medicinal market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Gene-based Advanced Therapy Medicinal is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Gene-based Advanced Therapy Medicinal is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Gene-based Advanced Therapy Medicinal is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Gene-based Advanced Therapy Medicinal include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and Sunway Biotech, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Gene-based Advanced Therapy Medicinal market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Gene-based Advanced Therapy Medicinal, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Gene-based Advanced Therapy Medicinal, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gene-based Advanced Therapy Medicinal revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Gene-based Advanced Therapy Medicinal market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Gene-based Advanced Therapy Medicinal revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and Sunway Biotech, etc.
By Company
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Segment by Type
Viral Gene Delivery System
Non-viral Gene Delivery System
Segment by Application
Neurological Diseases
Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Gene-based Advanced Therapy Medicinal in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene-based Advanced Therapy Medicinal companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene-based Advanced Therapy Medicinal revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene-based Advanced Therapy Medicinal Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Viral Gene Delivery System
1.2.3 Non-viral Gene Delivery System
1.3 Market by Application
1.3.1 Global Gene-based Advanced Therapy Medicinal Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene-based Advanced Therapy Medicinal Market Perspective (2018-2029)
2.2 Global Gene-based Advanced Therapy Medicinal Growth Trends by Region
2.2.1 Gene-based Advanced Therapy Medicinal Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gene-based Advanced Therapy Medicinal Historic Market Size by Region (2018-2023)
2.2.3 Gene-based Advanced Therapy Medicinal Forecasted Market Size by Region (2024-2029)
2.3 Gene-based Advanced Therapy Medicinal Market Dynamics
2.3.1 Gene-based Advanced Therapy Medicinal Industry Trends
2.3.2 Gene-based Advanced Therapy Medicinal Market Drivers
2.3.3 Gene-based Advanced Therapy Medicinal Market Challenges
2.3.4 Gene-based Advanced Therapy Medicinal Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Gene-based Advanced Therapy Medicinal by Players
3.1.1 Global Gene-based Advanced Therapy Medicinal Revenue by Players (2018-2023)
3.1.2 Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Players (2018-2023)
3.2 Global Gene-based Advanced Therapy Medicinal Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Gene-based Advanced Therapy Medicinal, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Gene-based Advanced Therapy Medicinal Market Concentration Ratio
3.4.1 Global Gene-based Advanced Therapy Medicinal Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene-based Advanced Therapy Medicinal Revenue in 2022
3.5 Global Key Players of Gene-based Advanced Therapy Medicinal Head office and Area Served
3.6 Global Key Players of Gene-based Advanced Therapy Medicinal, Product and Application
3.7 Global Key Players of Gene-based Advanced Therapy Medicinal, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene-based Advanced Therapy Medicinal Breakdown Data by Type
4.1 Global Gene-based Advanced Therapy Medicinal Historic Market Size by Type (2018-2023)
4.2 Global Gene-based Advanced Therapy Medicinal Forecasted Market Size by Type (2024-2029)
5 Gene-based Advanced Therapy Medicinal Breakdown Data by Application
5.1 Global Gene-based Advanced Therapy Medicinal Historic Market Size by Application (2018-2023)
5.2 Global Gene-based Advanced Therapy Medicinal Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gene-based Advanced Therapy Medicinal Market Size (2018-2029)
6.2 North America Gene-based Advanced Therapy Medicinal Market Size by Type
6.2.1 North America Gene-based Advanced Therapy Medicinal Market Size by Type (2018-2023)
6.2.2 North America Gene-based Advanced Therapy Medicinal Market Size by Type (2024-2029)
6.2.3 North America Gene-based Advanced Therapy Medicinal Market Share by Type (2018-2029)
6.3 North America Gene-based Advanced Therapy Medicinal Market Size by Application
6.3.1 North America Gene-based Advanced Therapy Medicinal Market Size by Application (2018-2023)
6.3.2 North America Gene-based Advanced Therapy Medicinal Market Size by Application (2024-2029)
6.3.3 North America Gene-based Advanced Therapy Medicinal Market Share by Application (2018-2029)
6.4 North America Gene-based Advanced Therapy Medicinal Market Size by Country
6.4.1 North America Gene-based Advanced Therapy Medicinal Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Gene-based Advanced Therapy Medicinal Market Size by Country (2018-2023)
6.4.3 North America Gene-based Advanced Therapy Medicinal Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Gene-based Advanced Therapy Medicinal Market Size (2018-2029)
7.2 Europe Gene-based Advanced Therapy Medicinal Market Size by Type
7.2.1 Europe Gene-based Advanced Therapy Medicinal Market Size by Type (2018-2023)
7.2.2 Europe Gene-based Advanced Therapy Medicinal Market Size by Type (2024-2029)
7.2.3 Europe Gene-based Advanced Therapy Medicinal Market Share by Type (2018-2029)
7.3 Europe Gene-based Advanced Therapy Medicinal Market Size by Application
7.3.1 Europe Gene-based Advanced Therapy Medicinal Market Size by Application (2018-2023)
7.3.2 Europe Gene-based Advanced Therapy Medicinal Market Size by Application (2024-2029)
7.3.3 Europe Gene-based Advanced Therapy Medicinal Market Share by Application (2018-2029)
7.4 Europe Gene-based Advanced Therapy Medicinal Market Size by Country
7.4.1 Europe Gene-based Advanced Therapy Medicinal Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Gene-based Advanced Therapy Medicinal Market Size by Country (2018-2023)
7.4.3 Europe Gene-based Advanced Therapy Medicinal Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Gene-based Advanced Therapy Medicinal Market Size (2018-2029)
8.2 China Gene-based Advanced Therapy Medicinal Market Size by Type
8.2.1 China Gene-based Advanced Therapy Medicinal Market Size by Type (2018-2023)
8.2.2 China Gene-based Advanced Therapy Medicinal Market Size by Type (2024-2029)
8.2.3 China Gene-based Advanced Therapy Medicinal Market Share by Type (2018-2029)
8.3 China Gene-based Advanced Therapy Medicinal Market Size by Application
8.3.1 China Gene-based Advanced Therapy Medicinal Market Size by Application (2018-2023)
8.3.2 China Gene-based Advanced Therapy Medicinal Market Size by Application (2024-2029)
8.3.3 China Gene-based Advanced Therapy Medicinal Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Gene-based Advanced Therapy Medicinal Market Size (2018-2029)
9.2 Asia Gene-based Advanced Therapy Medicinal Market Size by Type
9.2.1 Asia Gene-based Advanced Therapy Medicinal Market Size by Type (2018-2023)
9.2.2 Asia Gene-based Advanced Therapy Medicinal Market Size by Type (2024-2029)
9.2.3 Asia Gene-based Advanced Therapy Medicinal Market Share by Type (2018-2029)
9.3 Asia Gene-based Advanced Therapy Medicinal Market Size by Application
9.3.1 Asia Gene-based Advanced Therapy Medicinal Market Size by Application (2018-2023)
9.3.2 Asia Gene-based Advanced Therapy Medicinal Market Size by Application (2024-2029)
9.3.3 Asia Gene-based Advanced Therapy Medicinal Market Share by Application (2018-2029)
9.4 Asia Gene-based Advanced Therapy Medicinal Market Size by Region
9.4.1 Asia Gene-based Advanced Therapy Medicinal Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Gene-based Advanced Therapy Medicinal Market Size by Region (2018-2023)
9.4.3 Asia Gene-based Advanced Therapy Medicinal Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Gene-based Advanced Therapy Medicinal Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Gene-based Advanced Therapy Medicinal Market Size by Type
10.2.1 Middle East, Africa, and Latin America Gene-based Advanced Therapy Medicinal Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Gene-based Advanced Therapy Medicinal Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Gene-based Advanced Therapy Medicinal Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Gene-based Advanced Therapy Medicinal Market Size by Application
10.3.1 Middle East, Africa, and Latin America Gene-based Advanced Therapy Medicinal Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Gene-based Advanced Therapy Medicinal Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Gene-based Advanced Therapy Medicinal Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Gene-based Advanced Therapy Medicinal Market Size by Country
10.4.1 Middle East, Africa, and Latin America Gene-based Advanced Therapy Medicinal Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Gene-based Advanced Therapy Medicinal Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Gene-based Advanced Therapy Medicinal Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene-based Advanced Therapy Medicinal Introduction
11.1.4 Biogen Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2023)
11.1.5 Biogen Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene-based Advanced Therapy Medicinal Introduction
11.2.4 Novartis Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2023)
11.2.5 Novartis Recent Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Gene-based Advanced Therapy Medicinal Introduction
11.3.4 Gilead Sciences Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2023)
11.3.5 Gilead Sciences Recent Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Details
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Introduction
11.4.4 Sarepta Therapeutics Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2023)
11.4.5 Sarepta Therapeutics Recent Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Details
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2023)
11.5.5 Alnylam Pharmaceuticals Recent Developments
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Gene-based Advanced Therapy Medicinal Introduction
11.6.4 Amgen Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2023)
11.6.5 Amgen Recent Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Details
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Gene-based Advanced Therapy Medicinal Introduction
11.7.4 Spark Therapeutics Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2023)
11.7.5 Spark Therapeutics Recent Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Details
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Gene-based Advanced Therapy Medicinal Introduction
11.8.4 Akcea Therapeutics Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2023)
11.8.5 Akcea Therapeutics Recent Developments
11.9 Sunway Biotech
11.9.1 Sunway Biotech Company Details
11.9.2 Sunway Biotech Business Overview
11.9.3 Sunway Biotech Gene-based Advanced Therapy Medicinal Introduction
11.9.4 Sunway Biotech Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2023)
11.9.5 Sunway Biotech Recent Developments
11.10 SIBIONO
11.10.1 SIBIONO Company Details
11.10.2 SIBIONO Business Overview
11.10.3 SIBIONO Gene-based Advanced Therapy Medicinal Introduction
11.10.4 SIBIONO Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2023)
11.10.5 SIBIONO Recent Developments
11.11 AnGes
11.11.1 AnGes Company Details
11.11.2 AnGes Business Overview
11.11.3 AnGes Gene-based Advanced Therapy Medicinal Introduction
11.11.4 AnGes Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2023)
11.11.5 AnGes Recent Developments
11.12 Orchard Therapeutics
11.12.1 Orchard Therapeutics Company Details
11.12.2 Orchard Therapeutics Business Overview
11.12.3 Orchard Therapeutics Gene-based Advanced Therapy Medicinal Introduction
11.12.4 Orchard Therapeutics Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2023)
11.12.5 Orchard Therapeutics Recent Developments
11.13 Human Stem Cells Institute
11.13.1 Human Stem Cells Institute Company Details
11.13.2 Human Stem Cells Institute Business Overview
11.13.3 Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Introduction
11.13.4 Human Stem Cells Institute Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2023)
11.13.5 Human Stem Cells Institute Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
*If Applicable.